These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
534 related articles for article (PubMed ID: 20226302)
1. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. Staevska M; Popov TA; Kralimarkova T; Lazarova C; Kraeva S; Popova D; Church DS; Dimitrov V; Church MK J Allergy Clin Immunol; 2010 Mar; 125(3):676-82. PubMed ID: 20226302 [TBL] [Abstract][Full Text] [Related]
2. [The effect of 5-days of cetirizine, desloratadine, fexofenadine 120 and 180 mg, levocetirizine, loratadine treatment on the histamine-induced skin reaction and skin blood flow--a randomized, double-blind, placebo controlled trial]. Kłos K; Kruszewski J; Kruszewski R; Sułek K Pol Merkur Lekarski; 2006 Nov; 21(125):449-53. PubMed ID: 17345838 [TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy of levocetirizine 5 mg and desloratadine 5 mg in chronic idiopathic urticaria patients. Potter PC; Kapp A; Maurer M; Guillet G; Jian AM; Hauptmann P; Finlay AY Allergy; 2009 Apr; 64(4):596-604. PubMed ID: 19053988 [TBL] [Abstract][Full Text] [Related]
4. Comparison of effects of 5 and 10 mg oral desloratadine and levocetirizine on histamine-induced wheal and flare response in healthy volunteers. Bulca S; Bayramgürler D; Odyakmaz Demirsoy E; Yavuz M; Sikar Aktürk A; Bilen N; Kıran R J Dermatolog Treat; 2013 Dec; 24(6):473-6. PubMed ID: 23441762 [TBL] [Abstract][Full Text] [Related]
5. [Inhibition of histamine-induced wheel after a recommended single dose administration of 10 mg cetirizine, 5 mg desloratadine, 120 i 180 mg fexofenadine, 5 mg levocetirizine and 10 mg loratadine--a randomized, double-blind, placebo controlled trial]. Kruszewski J; Kłos K; Sułek K Pol Merkur Lekarski; 2006 Nov; 21(125):443-8. PubMed ID: 17345837 [TBL] [Abstract][Full Text] [Related]
6. Critical temperature threshold measurement for cold urticaria: a randomized controlled trial of H(1) -antihistamine dose escalation. Magerl M; Pisarevskaja D; Staubach P; Martus P; Church MK; Maurer M Br J Dermatol; 2012 May; 166(5):1095-9. PubMed ID: 22242678 [TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, active-controlled, parallel-group pilot study to compare the efficacy and sedative effects of desloratadine 5 mg with levocetirizine 5 mg in the treatment of chronic idiopathic urticaria. Hong JB; Lee HC; Hu FC; Chu CY J Am Acad Dermatol; 2010 Nov; 63(5):e100-2. PubMed ID: 20950731 [No Abstract] [Full Text] [Related]
9. Use of montelukast alone or in combination with desloratadine or levocetirizine in patients with persistent allergic rhinitis. Ciebiada M; Gorska-Ciebiada M; Barylski M; Kmiecik T; Gorski P Am J Rhinol Allergy; 2011; 25(1):e1-6. PubMed ID: 21711959 [TBL] [Abstract][Full Text] [Related]
10. Quality of life in patients with persistent allergic rhinitis treated with montelukast alone or in combination with levocetirizine or desloratadine. Ciebiada M; Ciebiada MG; Kmiecik T; DuBuske LM; Gorski P J Investig Allergol Clin Immunol; 2008; 18(5):343-9. PubMed ID: 18973097 [TBL] [Abstract][Full Text] [Related]
11. A comparison of levocetirizine and desloratadine in the histamine-induced wheal and flare response in human skin in vivo. Popov TA; Dumitrascu D; Bachvarova A; Bocsan C; Dimitrov V; Church MK Inflamm Res; 2006 Jun; 55(6):241-4. PubMed ID: 16955243 [TBL] [Abstract][Full Text] [Related]
12. A double dose of levocetirizine leads to better control of histamine-induced flare, wheal and itch in healthy donors. Tanizaki H; Nakamizo S; Nakahigashi K; Miyachi Y; Kabashima K Pharmacology; 2013; 92(1-2):71-4. PubMed ID: 23942038 [TBL] [Abstract][Full Text] [Related]
13. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children. Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127 [TBL] [Abstract][Full Text] [Related]
14. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. Nettis E; Colanardi MC; Paradiso MT; Ferrannini A Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373 [TBL] [Abstract][Full Text] [Related]
15. Night-time sedating H1 -antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: a randomized controlled trial. Staevska M; Gugutkova M; Lazarova C; Kralimarkova T; Dimitrov V; Zuberbier T; Church MK; Popov TA Br J Dermatol; 2014 Jul; 171(1):148-54. PubMed ID: 24472058 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of levocetirizine 10 mg versus a combination of levocetirizine 5 mg and montelukast 10 mg in chronic urticaria resistant to levocetirizine 5 mg: A double-blind, randomized, controlled trial. Sarkar TK; Sil A; Pal S; Ghosh C; Das NK Indian J Dermatol Venereol Leprol; 2017; 83(5):561-568. PubMed ID: 28656910 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of allergen-induced wheal and flare reactions by levocetirizine and desloratadine. Frossard N; Strolin-Benedetti M; Purohit A; Pauli G Br J Clin Pharmacol; 2008 Feb; 65(2):172-9. PubMed ID: 17953719 [TBL] [Abstract][Full Text] [Related]
18. Treatment of recalcitrant chronic urticaria with nonsedating antihistamines: is there evidence for updosing? Sánchez-Borges M; Caballero-Fonseca F; Capriles-Hulett A J Investig Allergol Clin Immunol; 2013; 23(3):141-4; quiz 2 p preceding 145. PubMed ID: 23967751 [TBL] [Abstract][Full Text] [Related]
19. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. Siebenhaar F; Degener F; Zuberbier T; Martus P; Maurer M J Allergy Clin Immunol; 2009 Mar; 123(3):672-9. PubMed ID: 19201016 [TBL] [Abstract][Full Text] [Related]
20. H1-antihistamines for chronic spontaneous urticaria. Sharma M; Bennett C; Cohen SN; Carter B Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD006137. PubMed ID: 25397904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]